News & Analysis on Clinical Trial Services & Contract Research And Development
Animal welfare group, PETA has reportedly targeted Pfizer, accusing them of also trying to avoid US animal welfare laws by exporting its animal testing to countries with no or poor animal welfare standards.
Singapore has successfully completed the first phase of its biomedical science (BMS) initiative and is now pushing the second phase forward in order to drive growth in its pharma industry further.
Canadian pharma manufacturer Bioxel has announced the filing of a second international patent application to secure the synthesis of paclitaxel and decetaxel - two taxane-based drugs effective against cancer.
Covance has invested in mass spectrometer technology that it hopes will give it the edge over other contract research organisations (CROs) in the safety testing of new drug candidates.
US-based drug maker Merck, has agreed to outsource some of its preclinical trial work to an Indian-based company, marking the first time the pharma giant has used an Indian company to conduct drug research.
The Servier Institute and Pasteur-Weizmann Council has awarded its annual prize in biomedical research to two scientists for their work in diabetes and autoimmunity, paving the way for improved treatment and an eventual cure for this debilitating...
Actelion has announced it is acquiring biopharmaceutical company CoTherix for $420m (€328m) with the objective of taking over and increasing the distribution of Ventavis, the only approved inhaled therapy for the treatment of Pulmonary Arterial...
DSM Venturing, the investment arm of the Dutch chemical giant, has announced it has snapped a 10 per cent share in pharma materials provider Micromuscle.
The Biotechnology Industry Organization (BIO) urged the World Health Organization (WHO) to change its International Nonproprietary Names (INN) policy for biological products at a meeting last week in Geneva.